EUVIMEDEUVIMED entdecken
Open Access

HDAC6 inhibition regulates substrate stiffness-mediated inflammation signaling in chondrocytes

Yang Zhang, Godfred K Tawiah, Yanjun Zhang, Xiaohu Wang, Xiaochun Wei, Weiyi Chen, Xiaohong Qiao, Quanyou Zhang

Acta Biochimica et Biophysica Sinica · 2023

DOI: 10.3724/abbs.2023144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2023. Verfasst von Yang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Shanxi Medical University, Jinzhong 030604, China. Hauptthemen laut MEDLINE: Chondrocytes, Osteoarthritis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a chronic disease and is difficult to cure. Chondrocytes are highly mechanosensitive. Therefore, mechanical therapies have received attention as a therapeutic direction for OA. The stiffness, as a critical cue of the extracellular matrix (ECM), affects cell growth, development, and death. In this study, we use polydimethylsiloxane (PDMS) to create substrates with varying stiffness for chondrocyte growth, interleukin-1β (IL-1β) treatment to mimic the inflammatory environment, and Tubastatin A (Tub A) to inhibit histone deacetylase 6 (HDAC6). Our results show that stiff substrates can be anti-inflammatory and provide a better matrix environment than soft substrates. Inhibition of HDAC6 improves the inflammatory environment caused by IL-1β and coordinates with inflammation to spread the chondrocyte area and primary cilia elongation. Without IL-1β and Tub A treatments, the length of the primary cilia rather than frequency is stiffness-dependent, and their length on stiff substrates are greater than that on soft substrates. In conclusion, we demonstrate that stiff substrates, inflammation, and inhibition of HDAC6 enhance the mechanosensitivity of primary cilia and mediate substrate stiffness to suppress inflammation and protect the matrix.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesOsteoarthritisHumansHistone Deacetylase 6InflammationSignal TransductionInterleukin-1beta

Stichwörter der Autor:innen

HDAC6chondrocyteinflammationmatrix metabolismprimary ciliasubstrate stiffness

Substanzen

Histone Deacetylase 6Interleukin-1betaHDAC6 protein, human

Autor:innen und Institutionen

  • Department of Histology and Embryology, Shanxi Medical University, Jinzhong 030604, China.
  • College of Biomedical Engineering, Taiyuan University of Technology, Taiyuan 030024, China.
  • Department of Orthopaedics, the Second Hospital of Shanxi Medical University, Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair, Shanxi Medical University, Taiyuan 030001, China.
  • Department of Orthopaedics, Lvliang Hospital Affiliated to Shanxi Medical University, Lvliang 033099, China.

Zitieren

APA

Zhang, Y., Tawiah, G. K., Zhang, Y., Wang, X., Wei, X., Chen, W., Qiao, X., & Zhang, Q. (2023). HDAC6 inhibition regulates substrate stiffness-mediated inflammation signaling in chondrocytes. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023144

Vancouver

Zhang Y, Tawiah GK, Zhang Y, Wang X, Wei X, Chen W, et al. HDAC6 inhibition regulates substrate stiffness-mediated inflammation signaling in chondrocytes. Acta Biochimica et Biophysica Sinica. 2023. doi:10.3724/abbs.2023144

BibTeX
@article{Zhang2023,
  author = {Zhang, Yang and Tawiah, Godfred K and Zhang, Yanjun and Wang, Xiaohu and Wei, Xiaochun and Chen, Weiyi and Qiao, Xiaohong and Zhang, Quanyou},
  title = {HDAC6 inhibition regulates substrate stiffness-mediated inflammation signaling in chondrocytes},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2023},
  doi = {10.3724/abbs.2023144}
}
Kostenlos starten →